Skip to content

Emotional Intelligence and Chronic Orofacial Pain

Emotional Intelligence and Chronic Orofacial Pain

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07280338
Acronym
IEDOF
Enrollment
88
Registered
2025-12-12
Start date
2026-02-09
Completion date
2027-02-09
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Emotional intelligence

Brief summary

Chronic pain, lasting more than three months, is a widespread health issue that negatively impacts daily life, leading to significant emotional distress and functional impairment. Emotional intelligence, defined as the ability to recognize and manage one's own emotions as well as those of others, has been linked to better communication skills and reduced stress, which is a well-known risk factor for chronic pain. Studies have highlighted a correlation between emotional intelligence and certain chronic pain conditions, such as fibromyalgia and migraines. However, no research has yet explored its role in painful temporomandibular disorders (TMD). Given the strong involvement of psychosocial factors in TMD etiology, a better understanding of these elements could improve pain management and pave the way for preventive interventions.

Detailed description

This project aims to compare emotional intelligence and various psychosocial factors (anxiety, depression, coping, emotional regulation) between patients with painful temporomandibular disorder (TMD) and a control group without TMD or chronic pain. The study is based on the administration of validated French-language questionnaires during routine dental medicine consultations. Each participant completes these questionnaires in approximately 15 minutes, without any modification to their care. The data collected will help assess the relationships between orofacial pain and emotional factors to improve the understanding and management of affected patients.

Interventions

OTHERQuestionnaire and Physical Exam

All included subjects will be required to complete the following questionnaires: Hospital Anxiety and Depression Scale (HADS) Brief-COPE for coping assessment Emotion Reactivity Scale (ERS) for emotional regulation Visual Analog Scale (VAS) for fatigue assessment Sociodemographic and psychosocial evaluation Trait Emotional Intelligence Questionnaire - Short Form (TEIQue-SF) for emotional intelligence assessment

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For all subjects: Major subject * Non-opposition obtained * For subjects in the TMD group: Diagnosis of temporomandibular dysfunction -No other diagnosis of chronic pain For subjects in the control group: -No diagnosis of chronic pain Non inclusion Criteria: * Subject not understanding French * Subject under legal protection (guardianship or curatorship) * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Measurement of emotional intelligence score between both groupsDay 0Measurement of emotional intelligence score assessed by the TEIQue-SF questionnaire : The short version consists of 33 items assessing four factors: well-being, self-control, emotionality, and sociability. Each item is rated on a Likert scale ranging from 1 ("strongly disagree") to 7 ("strongly agree").

Secondary

MeasureTime frameDescription
Measurement of anxiety disorders between both groupsDay 0Measurement of anxiety disorders between the two groups via the HAD-S questionnaire The HAD scale is a validated instrument in French, used to screen for anxiety and depressive disorders. It consists of 14 items scored from 0 to 3. Seven questions relate to anxiety (total A) and the other seven to the depressive dimension (total D), thus providing two scores (maximum score for each = 21). This questionnaire is routinely used during consultations in the oral health service and systematically used during specialized consultations for orofacial pain.
Measurement of the coping score between both groupsDay 0Measurement of the coping score assessed by the Brief-COPE questionnaire This instrument is an abbreviated version of the COPE inventory with 28 items. It includes 14 scales that assess distinct dimensions of coping: active coping, planning, instrumental social support seeking, emotional social support seeking, emotional expression, behavioral disengagement, distraction, blaming, positive reinterpretation, humor, denial, acceptance, religion, and substance use.
Measurement of emotional regulation score between both groupsDay 0Measurement of emotional regulation score assessed by the ERS questionnaire The ERS is a self-report questionnaire with 21 items designed to measure, using a single tool, three dimensions of emotional reactivity: emotional sensitivity, intensity, and persistence of emotions. Each item is rated on a Likert scale ranging from 0 ("does not apply to me at all") to 4 ("applies to me perfectly").
Measurement of fatigue score between both groupsDay 0Measurement of fatigue score assessed by an EVA scale (From 0 to 10)
Measurement of Depression disorders between both groupsDay 0Measurement of depression disorders between both groups via the HAD-S questionnaire The HAD scale is a validated instrument in French, used to screen for anxiety and depressive disorders. It consists of 14 items scored from 0 to 3. Seven questions relate to anxiety (total A) and the other seven to the depressive dimension (total D), thus providing two scores (maximum score for each = 21). This questionnaire is routinely used during consultations in the oral health service and systematically used during specialized consultations for orofacial pain.

Countries

France

Contacts

CONTACTAnais LE FUR-BONNABESSE, Dr
Anais.lefur-bonnabesse@chu-brest.fr0298223330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026